Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Lafora disease is a rare inherited neurodegenerative disease with onset in adolescence. Patients present with progressive myoclonic seizures and cognitive decline. The disease is linked to mutations in either of the two genes encoding malin and laforin, and it is associated with the accumulation of polyglucosan inclusions (Lafora bodies [LBs]) in various tissues, such as brain, liver, muscle, and skin, with the skin being particularly accessible for biopsy. Histopathologic examination of affected tissue with demonstration of LBs, together with the presence of pathologic mutation in EPM2A or NHLRC1 genes, is sufficient for diagnosis of this neurologic disorder when clinically suspected. Here, we report the case of a 16-year-old female with progressive neurologic symptoms and homozygous mutation in the NHLRC1 gene encoding malin. The skin biopsy was instrumental in reaching the final diagnosis by showing LBs in sweat glands by histopathologic and electron microscopic examination. © 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.


Krasimira A Rozenova, Julia S Lehman, Joseph P Grande, Anthony L Fine, Carilyn N Wieland. Utilization of skin biopsy for diagnosis in a case of Lafora disease. Journal of cutaneous pathology. 2022 Oct;49(10):885-888

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 35708461

View Full Text